熱門資訊> 正文
Fractyl Health报告第一季度业绩
2025-05-14 04:26
- Fractyl Health press release (NASDAQ:GUTS): Q1 Net loss was $23.7 million, compared to $3.3 million for the same period in 2024, largely due to the fluctuation in the non-cash change in fair value of notes and warrants and partially driven by increase in operating expenses of $3.2 million.
- As of March 31, 2025, Fractyl had approximately $42.1 million in cash and cash equivalents. Based on current operating plans, the Company believes its cash position will fund operations into the fourth quarter of 2025.
More on Fractyl Health
- Seeking Alpha’s Quant Rating on Fractyl Health
- Historical earnings data for Fractyl Health
- Financial information for Fractyl Health
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
